Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by PowerofNowon Feb 18, 2021 2:49pm
115 Views
Post# 32597979

RE:20 Minute Video with CEO💉💚WORTH WATCHING

RE:20 Minute Video with CEO💉💚WORTH WATCHING Generating an immune response from an oral delivery is not easy to do but IF WE CAN DO THAT I THINK THATS A GAME CHANGER" said David Goren, Vaxils Chairman and Chief Executive Officer.
" 5:51 IN THE SENSE THAT WHAT I KNOW¹, I KNOW² BUT THERES ALOT I DONT KNOW³ ABOUT HOW THE STOCK MARKET BEHAVES...

  AND PROBABLY NO ONE KNOWS SO.." 
said David Goren, Vaxil’s Chairman and Chief Executive Officer.... WATCH VIDEO IN FULL





My say:: Todays dump was one, last orchstrated attempt for the big guns to gain cheap shares!!!

For all one knows, this NR could have happened months or weeks back and is outdated but are materializing it only like it happened yesterday. For all we know the VAX has more results than one could imagine. There was immune response by the vaccine to the animals... Strong investors know WHO's involved here.




[/quote]

<< Previous
Bullboard Posts
Next >>